Does tramadol (opioid analgesic) cause vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Tramadol Cause Vomiting?

Yes, tramadol commonly causes vomiting, with FDA-reported incidence rates of 9% within 7 days, 13% within 30 days, and 17% within 90 days of treatment in chronic pain trials. 1

Incidence and Time Course of Vomiting

  • Vomiting is one of the most frequent adverse effects of tramadol, occurring alongside nausea as the primary gastrointestinal complications. 1
  • In chronic nonmalignant pain trials, the cumulative incidence of vomiting increases progressively: 9% by day 7,13% by day 30, and 17% by day 90. 1
  • Nausea occurs even more frequently than vomiting, with rates of 24% at 7 days, 34% at 30 days, and 40% at 90 days. 1
  • In cancer pain studies, patients on tramadol experienced "much more frequent adverse effects such as nausea, vomiting and constipation" compared to placebo. 2

Mechanism and Risk Factors

  • Tramadol's dual mechanism of action—weak mu-opioid receptor agonism combined with serotonin and norepinephrine reuptake inhibition—contributes to its gastrointestinal side effects. 3, 4
  • The serotonergic activity specifically increases the risk of nausea and vomiting, particularly when combined with other serotonergic medications (SSRIs, SNRIs, TCAs, MAOIs). 1
  • Adverse effects, particularly nausea and vomiting, are dose-dependent and considerably more likely with high loading doses. 5

Critical Strategies to Minimize Vomiting

Slower titration rates dramatically reduce the incidence of vomiting and treatment discontinuation. 6

  • A study comparing titration schedules found that 13-day and 16-day titration schedules resulted in significantly fewer discontinuations due to nausea/vomiting (22%) compared to a 10-day schedule (P=0.008 and P=0.006, respectively). 6
  • The rate of titration, rather than the target dose, is the major determinant of tolerability. 6
  • For intravenous administration, slower injection over 3 minutes significantly reduces the incidence of nausea and vomiting compared to 1-minute administration. 7

Practical Dosing Recommendations to Reduce Vomiting

  • Start tramadol at 25-50 mg once or twice daily, then increase by 50 mg every 3-7 days as tolerated, rather than starting at higher doses. 3
  • For elderly patients or those with renal impairment, begin at 25 mg every 12 hours and titrate even more slowly over days to weeks. 4, 8
  • Reduction of the loading dose during the first days of treatment is an important factor in improving tolerability. 5

Comparative Context

  • In randomized controlled trials comparing tramadol to hydrocodone/paracetamol, patients treated with tramadol had a significantly higher incidence of nausea, vomiting, vertigo, anorexia and asthenia. 2
  • When compared to codeine and hydrocodone, tramadol produced a significantly higher percentage of side effects overall. 2
  • The incidence of nausea and vomiting varies by route and setting: postoperative studies show higher rates (17.8% and 7.0% with intramuscular administration) compared to outpatient settings (4.2% and 0.5% in postmarketing surveillance). 9

Clinical Pitfalls to Avoid

  • Do not start at standard doses (50-100 mg every 4-6 hours) in opioid-naïve patients, as this dramatically increases the risk of vomiting and early discontinuation. 6, 5
  • Do not rapidly escalate doses—allow at least 3-7 days between dose increases. 3
  • Avoid combining tramadol with serotonergic medications when possible, as this increases both nausea/vomiting and the risk of serotonin syndrome. 1, 4
  • When administering intravenously, inject slowly over at least 3 minutes rather than rapid bolus to minimize acute nausea and vomiting. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Dosing Guidelines for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tramadol Dosing Considerations for Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Pharmacology of tramadol].

Drugs, 1997

Guideline

Tramadol Dosing Guidelines for Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.